EverSource Wealth Advisors »

Entrada Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9k 376 10.28
2025-09-30 $2.3k 389 5.81
2025-06-30 $47 7 6.71
2024-12-31 $241 14 17.29

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Value Etf Etf (VTV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
iShares Gold Trust ETF Etf (IAU)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Apple Stock (AAPL)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Nvidia Corporation Stock (NVDA)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Apollo Global Mgmt Stock (APO)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)

View all positions for EverSource Wealth Advisors

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics